tlooto
Sign up
Open AccessMedicine

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology.

R. Simon

2010Personalized Medicine

DOI: 10.2217/pme.09.49

tlooto Summary

This review attempts to address some of issues and provide guidance on the design of clinical trials for evaluating the clinical utility and robustness of prognostic and predictive biomarkers.

Abstract

Abstract is not available.

Citation format

SIMON, R. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Personalized Medicine, 2010, 7 1: 33–47.